Clinical Trial Update: Almonertinib Combined With Anlotinib as First-line Treatment for Advanced Non-small Cell Lung Cance [Phase 3]

View source ↗

Summary

Phase 3 clinical trial updating first-line treatment of advanced non-small cell lung cancer using a combination of almonertinib and anlotinib is currently recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Almonertinib (almonertinib)
• Anlotinib (anlotinib)

Snippet

Sponsor: Qianfoshan Hospital | Conditions: Advanced Non-small Cell Lung Cancer | Phase 3 | Status: RECRUITING